HealthDay News — Most individuals living in underserved communities believe that dermatologic side effects (DSEs) from anticancer therapies (ACTs) occur at high rates, according to a study published ...

HealthDay News — Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or obesity, according to a study ...

Palivizumab was the only approved therapy to prevent severe RSV disease in infants and young children until the approval of nirsevimab in 2023.

CELZ-201-DDT is a regenerative stem cell-based therapy being developed as a potential treatment for chronic low back pain associated with degenerative disc disease.

HealthDay News — Mailing a stool-based test directly to people’s homes is the most effective strategy for increasing colorectal cancer screening rates, according to a study published online August 4 ...

"If you see increased wastewater viral activity levels, it might indicate that there is a higher risk of infection." ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR.

Patients with postural orthostatic tachycardia syndrome treated with ivabradine have better heart-rate control when standing.

Forty-six point four percent said they would accept one or more missing vaccines if they could be provided during their ED visit.

Discordance was greater for middle-aged adults, racial and ethnic minorities, and for those with lower educational attainment.

Cylembio is a therapeutic cancer vaccine candidate that targets cells and immune-suppressive cells in the tumor microenvironment through activation and expansion of T cells against IDO1 and/or PD-L1 ...

Ianalumab added to eltrombopag significantly prolonged the time to treatment failure (TTF) in adults with primary immune thrombocytopenia (ITP), a B cell-driven autoimmune disease, according to phase ...